Brief: Intra-Cellular Therapies Reports Second Quarter 2022 Financial Results
Aug 9 (Reuters) - Intra-Cellular Therapies Inc ITCI.O :
* INTRA-CELLULAR THERAPIES REPORTS SECOND QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* Q2 REVENUE ROSE 178 PERCENT TO $55.6 MILLION
* QTRLY NET LOSS PER COMMON SHARE: BASIC & DILUTED $0.92
Source text for Eikon: ID:nGNX6bbVgL
Further company coverage: ITCI.O
Recent news on Intra-Cellular Therapies
See all newsBrief: Intra-Cellular Therapies stockholder filed lawsuit against co, board in NY Supreme Court
Intra-Cellular Therapies Inc reports results for the quarter ended December 31 - Earnings Summary
U.S. RESEARCH ROUNDUP-Apple, Caterpillar, Visa
Street View: New drug launches, ITCI deal to boost J&J's growth
J&J beats quarterly sales and profit estimates on cancer drug sales (updated)